Thomas D. Pfister

4.8k total citations
94 papers, 3.7k citations indexed

About

Thomas D. Pfister is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas D. Pfister has authored 94 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas D. Pfister's work include Cancer therapeutics and mechanisms (11 papers), Bone health and treatments (9 papers) and Bone and Joint Diseases (7 papers). Thomas D. Pfister is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Bone health and treatments (9 papers) and Bone and Joint Diseases (7 papers). Thomas D. Pfister collaborates with scholars based in United States, Switzerland and Germany. Thomas D. Pfister's co-authors include Yi Lu, Eckard Wimmer, Steven M. Berry, Denise Egger, Kurt Bienz, Frieder Bauss, Martin F. Bachmann, Robert J. Kinders, James H. Doroshow and Lutz Müller and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Thomas D. Pfister

91 papers receiving 3.6k citations

Peers

Countries citing papers authored by Thomas D. Pfister

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Pfister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Pfister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Pfister more than expected).

Fields of papers citing papers by Thomas D. Pfister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Pfister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Pfister. The network helps show where Thomas D. Pfister may publish in the future.

Co-authorship network of co-authors of Thomas D. Pfister

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Pfister. A scholar is included among the top collaborators of Thomas D. Pfister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Pfister. Thomas D. Pfister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach 2024 ·Regulatory Toxicology and Pharmacology ·(unknown), (unknown), (unknown), Nicole Clemann, (unknown), W. Anthony Hawkins, (unknown), (unknown), (unknown), (unknown), Thomas D. Pfister, (unknown), (unknown), Gregor Tuschl, Lisa Wiesner	3
2	Controlling cleaning agent residues in pharmaceutical manufacturing: A harmonized scientific strategy 2023 ·Regulatory Toxicology and Pharmacology ·(unknown), Thomas D. Pfister, (unknown), Nicole Clemann, (unknown), Lisa Wiesner, W. Anthony Hawkins, (unknown), K.J Versyck	0
3	Knowledge should not be lost! Interview with a volunteer 2023 ·Repository for Publications and Research Data (ETH Zurich) ·Nicole Graf, Thomas D. Pfister	1
4	Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays 2016 ·Clinical Cancer Research ·Apurva K. Srivastava, Melinda G. Hollingshead, Jennifer Weiner, Tony Navas, Yvonne A. Evrard, Sonny Khin, (unknown), Yiping Zhang, Suzanne Borgel, Thomas D. Pfister, Robert J. Kinders, Donald P. Bottaro, W. Marston Linehan, Joseph E. Tomaszewski, James H. Doroshow, Ralph E. Parchment	24
5	A harmonization effort for acceptable daily exposure derivation – Considerations for application of adjustment factors 2016 ·Regulatory Toxicology and Pharmacology ·Robert Sussman, Bruce D. Naumann, Thomas D. Pfister, (unknown), (unknown), Patricia A. Weideman	35
6	Identifying the Elusive Sites of Tyrosyl Radicals in Cytochrome c Peroxidase: Implications for Oxidation of Substrates Bound at a Site Remote from the Heme 2014 ·Biochemistry ·Kyle D. Miner, Thomas D. Pfister, Parisa Hosseinzadeh, (unknown), Lynda J. Donald, P.C. Loewen, Yi Lu, Anabella Ivancich	20
7	Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension 2013 ·European Respiratory Journal ·Marion Delcroix, Gérald Simonneau, Emmanuel Bergot, Anco Boonstra, John Granton, David Langleben, Pilar Escribano Subías, Nazzareno Galiè, Thomas D. Pfister, (unknown), Olivier Sitbon	1
8	Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function 2012 ·Journal of Pharmacological and Toxicological Methods ·Raoul Bergner, (unknown), Bettina Kränzlin, N. Gretz, Hilary Faust, Thomas D. Pfister	5
9	Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron 2010 ·Cancer Research ·William C. Reinhold, Jean‐Louis Mergny, Hongfang Liu, Michaël Ryan, Thomas D. Pfister, Robert J. Kinders, Ralph E. Parchment, James H. Doroshow, John N. Weinstein, Yves Pommier	60
10	Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells 2010 ·Clinical Cancer Research ·(unknown), Thomas D. Pfister, Ralph E. Parchment, Shivaani Kummar, Larry Rubinstein, Yvonne A. Evrard, Martin Gutierrez, Anthony J. Murgo, Joseph E. Tomaszewski, James H. Doroshow, Robert J. Kinders	75
11	Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity 2009 ·Molecular Cancer Therapeutics ·Thomas D. Pfister, William C. Reinhold, Keli Agama, Shalu Gupta, Sonny Khin, Robert J. Kinders, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow, Yves Pommier	126
12	Ethyl methanesulfonate toxicity in Viracept—A comprehensive human risk assessment based on threshold data for genotoxicity 2009 ·Toxicology Letters ·Lutz Müller, Elmar Gocke, Thierry Lavé, Thomas D. Pfister	66
13	Development and preclinical modeling of a topoisomerase I pharmacodynamic immunoassay for use in clinical trials 2008 ·Clinical Cancer Research ·Thomas D. Pfister, Sonny Khin, Melinda G. Hollingshead, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow, Robert J. Kinders	1
14	CYT006-AngQb, a vaccine against hypertension targeting angiotensin II, reduces early-morning and day-time blood pressure 2007 ·Circulation ·Alain C. Tissot, J. Nussberger, (unknown), H Stocker, Thomas D. Pfister, Frank Wagner, Paul S. Mueller, (unknown), (unknown)	6
15	A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity 2006 ·Journal of Hypertension ·Patrice M. Ambühl, Alain C. Tissot, Alma Fulurija, Patrik Maurer, Juerg Nussberger, Robert Sabat, Vera Nief, (unknown), (unknown), (unknown), Thomas D. Pfister, Manfred Rettenbacher, Hans‐Dieter Volk, Frank Wagner, Philipp Müller, Gary T. Jennings, Martin F. Bachmann	165
16	Kinetic and crystallographic studies of a redesigned manganese-binding site in cytochrome c peroxidase 2006 ·JBIC Journal of Biological Inorganic Chemistry ·Thomas D. Pfister, Amir Y. Mirarefi, (unknown), Xuan Zhao, (unknown), (unknown), Yi-Gui Gao, Howard Robinson, Charles F. Zukoski, Andrew H.‐J. Wang, Yi Lu	21
17	Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1 2005 ·The Journal of Experimental Medicine ·Dominique Gatto, Thomas D. Pfister, Andrea Jegerlehner, Stephen W. Martin, Manfred Köpf, Martin F. Bachmann	62
18	Acute Renal Effects of Intravenous Bisphosphonates in the Rat 2005 ·Basic & Clinical Pharmacology & Toxicology ·Thomas D. Pfister, (unknown), Bernd Bohrmann, Frieder Bauss	35
19	Protein kinase A: purification and characterization of the enzyme from two cold-hardy goldenrod gall insects 2002 ·Insect Biochemistry and Molecular Biology ·Thomas D. Pfister, Kenneth B. Storey	17
20	Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells 1992 ·Virology ·Thomas D. Pfister, Luis Pasamontes, (unknown), Denise Egger, Kurt Bienz	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact